Trade Summary

2 days ago, Podnos Yale, serving as Chief Medical Officer at Oncology Institute, Inc. (TOI), sold 23,451 shares at $5.38 per share, for a total transaction value of $126,093.68. Following this transaction, Podnos Yale now holds 259,527 shares of TOI.

This sale represents a 8.29% decrease in Podnos Yale's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 8, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 9, 2026 at 7:06 PM ET, 1 day after the trade was made.

Oncology Institute, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL CARE FACILITIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.